Recovery Updates from Robert

1. 1. 1. 1. I create my life.
         2. My intention is to create health and wellness for myself.
         3. I admire people who have recovered from Parkinson’s disease.
         4. To have my health makes my life more enjoyable and rewarding.
         5. I get well by doing what I love.
         6. I deserve to be well because I add value to other people’s lives.
         7. I fully and completely receive the healing that is offered to me by my friends and family.
         8. I am truly grateful for the health that I have.
         9. Opportunities for recovery come my way every day.
         10. My capacity to recover expands with each passing day.

In the spirit of providing additional benefits for Parkinsons Recovery members, I want you all to know that there is a 50% tuition discount for all of my courses. Just enter the coupon code succeed on the shopping cart for any of the tuition options on any of the courses (1 month., 3 months, 6 months). 

I have devoted much of my time and energy to developing classes for the courses and want to make sure any of the are available to your at an affordable cost. 

Many blessings to all –

Robert
360-789-1658 

The two studies below do not specifically evaluate the impact of the X39 Stem Cell Patches on any chronic conditions specifically. They do offer support on the impact of the peptide secreted by the patches on the rejuvenation of stem cells throughout the body. Stem cells facilitate healing of all chronic conditions.

Brain Sci. 2017 Feb 15;7(2):20. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline.Loren Pickart, Jessica Michelle Vasquez-Soltero, Anna Margolina

Abstract

Neurodegeneration, the progressive death of neurons, loss of brain function, and cognitive decline is an increasing problem for senior populations. Its causes are poorly understood and therapies are largely ineffective. Neurons, with high energy and oxygen requirements, are especially vulnerable to detrimental factors, including age-related dysregulation of biochemical pathways caused by altered expression of multiple genes. GHK (glycyl-l-histidyl-l-lysine) is a human copper-binding peptide with biological actions that appear to counter aging-associated diseases and conditions.

GHK, which declines with age, has health promoting effects on many tissues such as chondrocytes, liver cells and human fibroblasts, improves wound healing and tissue regeneration (skin, hair follicles, stomach and intestinal linings, boney tissue), increases collagen, decorin, angiogenesis, and nerve outgrowth, possesses anti-oxidant, anti-inflammatory, anti-pain and anti-anxiety effects, increases cellular stemness and the secretion of trophic factors by mesenchymal stem cells.

Studies using the Broad Institute Connectivity Map show that GHK peptide modulates expression of multiple genes, resetting pathological gene expression patterns back to health. GHK has been recommended as a treatment for metastatic cancer, Chronic Obstructive Lung Disease, inflammation, acute lung injury, activating stem cells, pain, and anxiety. Here, we present GHK’s effects on gene expression relevant to the nervous system health and function.

Biomed Res Int. 2014:2014:151479. GHK and DNA: resetting the human genome to health. Loren Pickart, Jessica Michelle Vasquez-Soltero, Anna Margolina 

Abstract

During human aging there is an increase in the activity of inflammatory, cancer promoting, and tissue destructive genes plus a decrease in the activity of regenerative and reparative genes. The human blood tripeptide GHK possesses many positive effects but declines with age. It improves wound healing and tissue regeneration (skin, hair follicles, stomach and intestinal linings, and boney tissue), increases collagen and glycosaminoglycans, stimulates synthesis of decorin, increases angiogenesis, and nerve outgrowth, possesses antioxidant and anti-inflammatory effects, and increases cellular stemness and the secretion of trophic factors by mesenchymal stem cells.

Recently, GHK has been found to reset genes of diseased cells from patients with cancer or COPD to a more healthy state. Cancer cells reset their programmed cell death system while COPD patients’ cells shut down tissue destructive genes and stimulate repair and remodeling activities. In this paper, we discuss GHK’s effect on genes that suppress fibrinogen synthesis, the insulin/insulin-like system, and cancer growth plus activation of genes that increase the ubiquitin-proteasome system, DNA repair, antioxidant systems, and healing by the TGF beta superfamily. A variety of methods and dosages to effectively use GHK to reset genes to a healthier state are also discussed.

Photobiomodulation Parkinson’s Study Results Released

Finally! I have been eagerly waiting to learn results of a 3 year Australian photobiomodulation Parkinson’s study that examined the impact of light therapy (using Vielight.com devices) on symptoms of persons diagnosed with Parkinson’s. Results have finally been published.

Documented reductions in symptoms far exceeded my expectations. Measures of mobility, cognition, dynamic balance and fine motor skill for the 12 Parkinson’s research subjects were significantly improved (p < 0.05) with photobiomodulation treatment for 12 weeks and up to one year. Many individual improvements were above the minimal clinically important difference, the threshold judged to be meaningful for participants. Individual improvements varied but many continued for up to one year with sustained home treatment.

The design of this study was eloquent. Participants were assessed for mobility, fine motor skills, balance and cognition before treatment began, after 4 weeks of treatment, after 12 weeks of treatment and the end of the home treatment period.

Researchers drew the following conclusions:

“PBM (photobiomodulation) was shown to be a safe and potentially effective treatment for a range of clinical signs and symptoms of PD. Improvements were maintained for as long as treatment continued, for up to one year in a neurodegenerative disease where decline is typically expected.” 

Contact the company: https://www.vielight.com  for information about their photobiomodulation devices and recommendations. The company has offered a 10% discount to members of my audience.  Enter the coupon code healing4me on the shopping card or tell them when you call (877-355-8012) that you are with Parkinsons Recovery. The 10% discount will automatically be applied. The company is located in Toronto Canada.

I continue to hear positive reports from members of my audience about the beneficial effects of photobiomodulation therapy. I have identified dozens of natural therapies that offer symptom relief, but would have to put this particular therapy as one of the natural options that promises to offer the most benefit for most (but not all) persons. Consider this option to be worth serious consideration.

Robert

PS: I give myself photobiomodulation therapy every other day using the X-Plus Vielight device. The downside is that it does require a 20 minute commitment for each treatment. Speaking only for myself, I cannot do anything other than do the treatment. The upside is that my mental function has increased substantially: I can remember details now and retrieve mountains of information from long term memory.  This really is an amazing therapy!

What follows is an abstract of the study:

BMC Neurol. 2021 Jul 2;21(1):256

Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study.

Ann Liebert, Brian Bicknell, E-Liisa Laakso, Gillian Heller, Parastoo Jalilitabaei, Sharon Tilley, John Mitrofanis, Hosen Kiat 

Abstract

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons.

Objective: To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcranial and remote treatment, in order to inform on best practice for a larger randomized placebo-controlled trial (RCT).

Methods: Twelve participants with idiopathic PD were recruited. Six were randomly chosen to begin 12 weeks of transcranial, intranasal, neck and abdominal PBM. The remaining 6 were waitlisted for 14 weeks before commencing the same treatment. After the 12-week treatment period, all participants were supplied with PBM devices to continue home treatment. Participants were assessed for mobility, fine motor skills, balance and cognition before treatment began, after 4 weeks of treatment, after 12 weeks of treatment and the end of the home treatment period. A Wilcoxon Signed Ranks test was used to assess treatment effectiveness at a significance level of 5%.

Results: Measures of mobility, cognition, dynamic balance and fine motor skill were significantly improved (p < 0.05) with PBM treatment for 12 weeks and up to one year. Many individual improvements were above the minimal clinically important difference, the threshold judged to be meaningful for participants. Individual improvements varied but many continued for up to one year with sustained home treatment. There was a demonstrable Hawthorne Effect that was below the treatment effect. No side effects of the treatment were observed.

Conclusions: PBM was shown to be a safe and potentially effective treatment for a range of clinical signs and symptoms of PD. Improvements were maintained for as long as treatment continued, for up to one year in a neurodegenerative disease where decline is typically expected. Home treatment of PD by the person themselves or with the help of a carer might be an effective therapy option. The results of this study indicate that a large RCT is warranted.